Anbio Biotechnology (NNNN) Income Statement

Anbio Biotechnology reported revenue of $8.65M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 5.6% from $8.19M a year earlier. Net income was $6.40M, up 169.9% year over year, a net margin of 74.1%. Gross margin was 87.2% and operating margin 66.7%.

Anbio Biotechnology Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Anbio Biotechnology income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	8.65	8.19	6.71	23.54	4.43
Cost of Revenue	1.10	2.30	3.35	10.98	1.89
Gross Profit	7.54	5.89	3.36	12.56	2.54
Operating Expenses
Research & Development	0.20	0.45	0.13	0.20	0.00
Selling, General & Administrative	1.57	3.44	1.27	2.17	0.09
Operating Expenses	1.78	3.89	1.40	2.37	0.09
Operating Income	5.77	2.00	1.96	10.20	2.46
Other Income/Expense
Interest Income	0.14	0.34	0.17	0.04	0.00
Interest Expense	0.00	0.00	0.00	0.01	0.00
Other Income/Expense	0.64	0.38	0.13	-0.18	0.08
Income
Income Before Tax	6.40	2.37	2.25	10.01	2.54
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	6.40	2.37	2.25	10.01	2.54
Net Income - Continuous Operations	6.40	2.37	2.25	10.01	2.54
Net Income - Discontinued Operations	-	-	-	-	-
EBITDA	5.77	2.00	1.97	10.03	2.46
EBIT	5.77	2.00	1.96	10.20	2.46
Depreciation & Amortization	0.00	0.00	0.01	0.01	0.00
Earnings Per Share
Basic EPS	-	-	-	-	25358.00
Diluted EPS	-	-	-	-	25358.00
Basic Shares Outstanding	43.67	42.29	143.89	143.89	0.00
Diluted Shares Outstanding	43.67	42.29	187.78	143.89	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Dec 31, 2025. Data sources and methodology

Frequently Asked Questions About Anbio Biotechnology Financial Statements

What was Anbio Biotechnology's revenue in fiscal 2025?

Anbio Biotechnology reported revenue of $8.65M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 5.6% from $8.19M a year earlier.

Is Anbio Biotechnology profitable?

Yes. Anbio Biotechnology earned net income of $6.40M in fiscal 2025, a net margin of 74.1%. In fiscal 2024 it earned $2.37M.

What is Anbio Biotechnology's operating margin?

Anbio Biotechnology's operating income was $5.77M on revenue of $8.65M in fiscal 2025, an operating margin of 66.7%, compared with 24.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition